Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-26-062706

Chief Medical Officer sold 623 shares at $17.90 ($11,152)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Im Ellie Eunkyung · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-16 Sale : show line 1 in the form 10b5-1 −623 $17.90 $11,152 21,446 D
Open-market sales · 623 sh · avg $17.90 · $11,152
Loading xslF345X06/wk-form4_1789761777.xml…